Working hours:

We accept orders 24/7

0
My order
Add items to wish list
Add items to comparison

Zhenoluten 20

SKU 7020080
Coming soon
Description

PRODUCTS DESCRIPTION

The efficiency of “Zhenoluten” was confirmed during clinical studies. It is effective for the complex restoration of female reproductive system function in case of pathological conditions of various genesis. This includes ovarian hypofunction, disturbance of the menstrual cycle, climacteric frustration, female infertility caused by disorders of the hormonal status, and is effective for women of senior age groups for the optimization of the reproductive system function. 

Recommended:

  • In case of ovarian dysfunction;
  • In case of disruptions of the menstrual cycle;
  • In case of endometriosis;
  • In case of female infertility;
  • In case of menopause anger;
  • In case of hormonedependent diseases of the female reproductive system;
  • In case of decreased libido.

Ingredients:

microcrystalline cellulose (bulking agent); hydroxypropyl methylcellulose (capsule shell), water, carrageenan (thickener), potassium acetate (acidity regulator); peptide complex A-15, containing amino acids (glutamic acid, aspartic acid, alanine, leucine, valine, isoleucine, proline, serine); calcium salts of fatty acids (anti-caking agent).

The recommended daily dose, or 2 or 4 capsules, contains 20 mg or 40 mg of peptide complex А-15.

Recommendations for use:

adults by 1 or 2 capsules 2 times a day during meals. Duration of use is 1 month. The use can be repeated after 3-6 months.

€40
€46
Compare
Sign in
to add this item to wishlist
%
Sign in to see your personal discount
Notify me when back in stock
Sign in to
add the product to the waiting list
A new review or comment
Rate this item
Send
Up

We care about your privacy

This website uses cookies for marketing and statistical purposes and for a secure and optimal site experience. You can change this in your browser settings. Click on the «Accept cookies» button to consent using cookies. You can read more on the User agreement page.